Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2019 Volume 19 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2019 Volume 19 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer

  • Authors:
    • Jing Wu
    • Xin‑Xin Ge
    • Wenyu Zhu
    • Qiaoming Zhi
    • Meng‑Dan Xu
    • Weiming Duan
    • Kai Chen
    • Fei‑Ran Gong
    • Min Tao
    • Liu‑Mei Shou
    • Meng‑Yao Wu
    • Wen‑Jie Wang
  • View Affiliations / Copyright

    Affiliations: Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, Jiangsu 213000, P.R. China, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China, Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310006, P.R. China
  • Pages: 2330-2340
    |
    Published online on: January 10, 2019
       https://doi.org/10.3892/mmr.2019.9844
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The count and classification of white blood cells (WBCs) may be used as prognostic markers in certain types of cancer. The present study investigated the prognostic potential of the counts of WBCs, including lymphocytes (LYs), monocytes (MOs), neutrophils (NEs), eosinophils (EOs) and basophils (BAs), in the prognosis of resectable colorectal cancer. The present study recruited 153 resectable colorectal cancer cases retrospectively, which were pathologically confirmed. All patients were divided into two groups, according to the median value of LY (low LY, ≤1.632x109/l or high LY, >1.632x109/l), MO (low MO, ≤0.330x109/l or high MO, >0.330x109/l), NE (low NE, ≤3.600x109/l or high NE, >3.600x109/l), EO (low EO, ≤0.085x109/l or high EO, >0.085x109/l), BA (low BA, ≤0.010x109/l or high BA, >0.010x109/l), or WBC (low WBC, ≤5.780x109/l or high WBC, >5.780x109/l). To evaluate the alterations in WBC counts following surgery and adjuvant chemotherapy; all samples received oxiplatin and capecitabine (XELOX) for 6‑8 cycles or 5‑fluorouracil, leucovorin and oxaliplatin (mFOLFOX6) for 10‑12 cycles. XELOX included oxaliplatin administered intravenously at a dose of 130 mg/m2 on day 1 and 850‑1,250 mg/m2 capecitabine twice daily for days 1‑14, repeated every 3 weeks. mFOLFOX6 included oxaliplatin administered intravenously at a dose of 85 mg/m2, 400 mg/m2 leucovorin and 400 mg/m2 5‑FU on day 1 followed by 1,200 mg/m2/days continuous infusion for 2 days (in total, 2,400 mg/m2 over 46‑48 h), repeated every 2 weeks. The present study investigated the post/pre‑treatment of LY, MO, NE, EO, BA and WBC ratios (≤1 indicated that LY, MO, NE, EO, BA and WBC counts were not increased following therapy; whereas, >1 suggested increased counts). Kaplan‑Meier curves were constructed to demonstrate overall survival (OS). A multivariate and univariate logistic regression analyses model was employed to identify the independent risk factors. Low pre‑treatment BA counts were associated with larger tumor size (>5 cm); pre‑treatment BA levels were positively associated with OS. Surgery significantly decreased the count of BAs and increased the count of EOs; whereas, no effect was observed on LYs, MOs, NEs or WBCs. Adjuvant chemotherapy markedly decreased the counts of LY, NE and WBC; whereas, no notable effects on MOs, EOs or BAs were observed. Whole course treatment (surgery combined with adjuvant chemotherapy) significantly decreased the values of LY, NE and WBC; however, increased the value of EO; no effects on the MO or BA counts were observed. An increased post‑/pre‑treatment NE ratio suggested poorer prognosis. Multivariate Cox regression analysis revealed that sex, tumor size, pre‑treatment BA count and the post‑/pre‑treatment NE ratio were independent prognostic factors affecting OS. The results of the present study suggested that the pre‑treatment BA count and post‑/pre‑treatment NE ratio may be potential prognostic factors for resectable colorectal cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Gennari L, Doci R and Rossetti C: Prognostic factors in colorectal cancer. Hepatogastroenterology. 47:310–314. 2000.PubMed/NCBI

3 

Kim MN, Kang JM, Yang JI, Kim BK, Im JP, Kim SG, Jung HC, Song IS and Kim JS: Clinical features and prognosis of early colorectal cancer treated by endoscopic mucosal resection. J Gastroenterol Hepatol. 26:1619–1625. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Hussain SP and Harris CC: Inflammation and cancer: An ancient link with novel potentials. Int J Cancer. 121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Cimen HI, Halis F, Saglam HS and Gokce A: Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer? Int Braz J Urol. 43:67–72. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Sun H, Yin CQ, Liu Q, Wang F and Yuan CH: Clinical signi fi cance of routine blood test-associated inflammatory index in breast cancer patients. Med Sci Monit. 23:5090–5095. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Arthur R, Williams R, Garmo H, Holmberg L, Stattin P, Malmström H, Lambe M, Hammar N, Walldius G, Robinsson D, et al: Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer. 142:2254–2262. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Su MC, Cheng CY and Wang PC: A neural-network-based approach to white blood cell classification. ScientificWorldJournal 2014. 7963712014.

9 

Spergel J and Aceves SS: Allergic components of eosinophilic esophagitis. J Allergy Clin Immunol. 142:1–8. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Cao C, Gu Y, Zhu C, Palmai-Pallag T, Lan F, Chen Z, Li W, Shen H and Ying S: Potential roles of eosinophils in cancer therapy: Epidemiological studies, experimental models, and clinical pathology. Recent Pat Anticancer Drug Discov. 9:241–248. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Siracusa MC, Kim BS, Spergel JM and Artis D: Basophils and allergic inflammation. J Allergy Clin Immunol. 132:789–801. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, Horgan PG and McMillan DC: Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer. 109:24–28. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Zhang J, Zhang HY, Li J, Shao XY and Zhang CX: The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: A systematic review and meta-analysis. Oncotarget. 8:68837–68846. 2017.PubMed/NCBI

14 

Watt DG, Martin JC, Park JH, Horgan PG and McMillan DC: Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer. Am J Surg. 210:24–30. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Iwase R, Shiba H, Haruki K, Fujiwara Y, Furukawa K, Futagawa Y, Wakiyama S, Misawa T and Yanaga K: Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma. Anticancer Res. 33:3439–3444. 2013.PubMed/NCBI

16 

Shen SL, Fu SJ, Huang XQ, Chen B, Kuang M, Li SQ, Hua YP, Liang LJ and Peng BG: Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer. 14:7442014. View Article : Google Scholar : PubMed/NCBI

17 

Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR, et al: Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 10:3411–3418. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Hosmer DW Jr and Lemeshow S: Applied Logistic Regression, Second Edition. 2000.PubMed/NCBI

21 

Wang C, Chen YG, Gao JL, Lyu GY, Su J, Zhang QI, Ji X, Yan JZ, Qiu QL, Zhang YL, et al: Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. Oncol Lett. 10:754–760. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, Chen HG and Gu LJ: Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol. 30:3522013. View Article : Google Scholar : PubMed/NCBI

23 

Wang M, Li C, Wen TF, Peng W and Chen LP: Postoperative low absolute lymphocyte counts may predict poor outcomes of hepatocellular carcinoma after liver resection. Chin Med J (Engl). 129:536–541. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Lee YY, Choi CH, Sung CO, Do IG, Hub SJ, Kim HJ, Kim TJ, Lee JW, Bae DS and Kim BG: Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer. Gynecol Oncol. 127:107–113. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Nagai S, Abouljoud MS, Kazimi M, Brown KA, Moonka D and Yoshida A: Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 97:694–701. 2014.PubMed/NCBI

26 

Gooden MJ, de Bock GH, Leffers N, Daemen T and Nijman HW: The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis. Br J Cancer. 105:93–103. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Yu P and Fu YX: Tumor-infiltrating T lymphocytes: Friends or foes? Lab Invest. 86:231–245. 2006. View Article : Google Scholar : PubMed/NCBI

28 

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, et al: Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 132:2328–2339. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, Morris LS, Coleman N and Alexander GJ: Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol. 45:246–253. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Li QQ, Lu ZH, Yang L, Lu M, Zhang XT, Li J, Zhou J, Wang XC, Gong JF, Gao J, et al: Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 15:945–950. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC and Clarke SJ: The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Fox P, Hudson M, Brown C, Lord S, Gebski V, De Souza P and Lee CK: Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer. 109:147–153. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK and Vauthey JN: Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol. 16:614–622. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, et al: Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level. Gynecol Oncol. 124:92–97. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Qi Q, Geng Y, Sun M, Wang P and Chen Z: Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer. Pancreatology. 15:145–150. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Mantovani A, Sica A and Locati M: New vistas on macrophage differentiation and activation. Eur J Immunol. 37:14–16. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Pollard JW: Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 84:623–630. 2008. View Article : Google Scholar : PubMed/NCBI

39 

De Palma M and Naldini L: Angiopoietin-2 TIEs up macrophages in tumor angiogenesis. Clin Cancer Res. 17:5226–5232. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Mitchem JB, Brennan DJ, Knolhoff BL, Belt BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D, et al: Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 73:1128–1141. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A and Clarke SJ: The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 265:539–546. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Legrand F, Driss V, Delbeke M, Loiseau S, Hermann E, Dombrowicz D and Capron M: Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol. 185:7443–7451. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Thompson AC, Bradley PJ and Griffin NR: Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am J Surg. 168:469–471. 1994. View Article : Google Scholar : PubMed/NCBI

44 

Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, Moretta L, Colonna M and Levi-Schaffer F: 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol. 174:110–118. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Sassler AM, McClatchey KD, Wolf GT and Fisher SG: Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma. Veterans Administration Laryngeal Cooperative Study Group. Laryngoscope. 105:413–416. 1995. View Article : Google Scholar : PubMed/NCBI

46 

von Wasielewski R, Seth S, Franklin J, Fischer R, Hübner K, Hansmann ML, Diehl V and Georgii A: Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood. 95:1207–1213. 2000.PubMed/NCBI

47 

De Monte L, Wörmann S, Brunetto E, Heltai S, Magliacane G, Reni M, Paganoni AM, Recalde H, Mondino A, Falconi M, et al: Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients. Cancer Res. 76:1792–1803. 2016. View Article : Google Scholar : PubMed/NCBI

48 

Cihan YB, Arslan A, Cetindag MF and Mutlu H: Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev. 15:4225–4231. 2014. View Article : Google Scholar : PubMed/NCBI

49 

White WM: Geochemistry: Portrait of Earth's coming of age. Nature. 485:452–453. 2012. View Article : Google Scholar : PubMed/NCBI

50 

Anthony HM: Blood basophils in lung cancer. Br J Cancer. 45:209–216. 1982. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu J, Ge XX, Zhu W, Zhi Q, Xu MD, Duan W, Chen K, Gong FR, Tao M, Shou LM, Shou LM, et al: Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Mol Med Rep 19: 2330-2340, 2019.
APA
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W. ... Wang, W. (2019). Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Molecular Medicine Reports, 19, 2330-2340. https://doi.org/10.3892/mmr.2019.9844
MLA
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W., Chen, K., Gong, F., Tao, M., Shou, L., Wu, M., Wang, W."Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer". Molecular Medicine Reports 19.3 (2019): 2330-2340.
Chicago
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W., Chen, K., Gong, F., Tao, M., Shou, L., Wu, M., Wang, W."Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer". Molecular Medicine Reports 19, no. 3 (2019): 2330-2340. https://doi.org/10.3892/mmr.2019.9844
Copy and paste a formatted citation
x
Spandidos Publications style
Wu J, Ge XX, Zhu W, Zhi Q, Xu MD, Duan W, Chen K, Gong FR, Tao M, Shou LM, Shou LM, et al: Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Mol Med Rep 19: 2330-2340, 2019.
APA
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W. ... Wang, W. (2019). Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Molecular Medicine Reports, 19, 2330-2340. https://doi.org/10.3892/mmr.2019.9844
MLA
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W., Chen, K., Gong, F., Tao, M., Shou, L., Wu, M., Wang, W."Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer". Molecular Medicine Reports 19.3 (2019): 2330-2340.
Chicago
Wu, J., Ge, X., Zhu, W., Zhi, Q., Xu, M., Duan, W., Chen, K., Gong, F., Tao, M., Shou, L., Wu, M., Wang, W."Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer". Molecular Medicine Reports 19, no. 3 (2019): 2330-2340. https://doi.org/10.3892/mmr.2019.9844
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team